aduhelm

Cognitive decline varies widely among people who have started experiencing memory and thinking problems or who are in the earliest stage of Alzheimer’s — the patients who received Aduhelm.

Scientists may have to wait many years to find out whether Aduhelm is actually effective because the drug was approved using FDA's accelerated pathway.